BioMarin Pharmaceutical
BMRN
#1907
Rank
ยฃ7.70 B
Marketcap
ยฃ40.08
Share price
-0.78%
Change (1 day)
-22.69%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - Total debt

Total debt on the balance sheet as of September 2025 : ยฃ0.45 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's total debt is ยฃ0.45 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BioMarin Pharmaceutical - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-12-31ยฃ0.48 B-44.16%
2023-12-31ยฃ0.86 B-4.83%
2022-12-31ยฃ0.90 B11.97%
2021-12-31ยฃ0.80 B1.23%
2020-12-31ยฃ0.79 B21.75%
2019-12-31ยฃ0.65 B0.11%
2018-12-31ยฃ0.65 B-24.72%
2017-12-31ยฃ0.86 B56.94%
2016-12-31ยฃ0.55 B23.9%
2015-12-31ยฃ0.44 B8.23%
2014-12-31ยฃ0.41 B3.9%
2013-12-31ยฃ0.39 B84.47%
2012-12-31ยฃ0.21 B-3.86%
2011-12-31ยฃ0.22 B-8.36%
2010-12-31ยฃ0.24 B-20.39%
2009-12-31ยฃ0.30 B-20.71%
2008-12-31ยฃ0.38 B54.75%
2007-12-31ยฃ0.25 B112.55%
2006-12-31ยฃ0.11 B-9.42%
2005-12-31ยฃ0.13 B-7.82%
2004-12-31ยฃ0.14 B101.89%
2003-12-31ยฃ69.87 M
2001-12-31ยฃ3.82 M6785.71%
2000-12-31ยฃ0.05 M-19.05%
1999-12-31ยฃ0.06 M14.23%
1998-12-31ยฃ0.06 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Ultragenyx Pharmaceutical
RARE
ยฃ25.39 M-94.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
ยฃ19.08 M-95.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
ยฃ0.23 B-49.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ19.16 B 4,125.35%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
ยฃ0.33 B-26.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
ยฃ2.16 M-99.52%๐Ÿ‡บ๐Ÿ‡ธ USA